We are actively raising our second investment round and expect to fill out the round quickly. Don’t miss out.
Non-UK investors email us at hello@thinksono.com
ThinkSono has built the right software to train even novice users how to give a proper ultrasound. Additionally, the startup based in London is building the world’s first software that detects deep vein thrombosis (DVT) with nurses in as little as 5 minutes
Our mobile app interacts directly with the ultrasound scanner, enabling simultaneous scanning and AI-guidance for training. Exams are uploaded to the Cloud Dashboard to receive feedback from an expert or colleague.
AutoDVT enables all healthcare professionals to perform deep vein thrombosis (DVT) scans at the point of care. It’s the world’s first non-invasive solution that can be driven at the point of care instead of through an elaborate testing process. Nurses can now detect DVT in as little as five minutes.
8 hospitals in the UK and 1 in Greece.
Investment overview
ThinkSono is a startup based in London. We are currently building the world’s first software that can help any healthcare provider detect deep vein thrombosis (DVT) in as little as 5 minutes. You can become part of the team by investing in our company during our second funding stage. We’re currently accepting investments but the round won’t last long. Here are the details:
We’ve been featured throughout the industry as a leader in improving ultrasound.
Non-invasive diagnosis of deep vein thrombosis from ultrasound imaging with machine learning.
The State of Ultrasound Technology with Dr. Greg Fritz and ThinkSono CEO Fouad Al-Noor.
Non-invasive diagnosis of deep vein thrombosis from ultrasound imaging with machine learning.
Fouad Al Noor
Chief Executive Officer & Co-Founder
Fouad has a masters in Electronic Engineering with Nanotechnology from the University of Southampton, where he wrote his thesis on paper-based medical diagnostics using image processing. He worked as a medical software engineer at SAP in California, and as a research assistant at Imperial College London before joining Entrepreneur First.
Sven Mischkewitz
Chief Technology Officer & Co-Founder
Sven is an award-winning software engineer from Hasso-Plattner-Institute, Germany. Before joining Entrepreneur First, he worked on annotation tools for brain cells on projects for the Max-Planck-Institute for Brain Research. He focused on the field of Human-Computer-Interaction during his studies.
Disclosures
ThinkSono AI is not a medical device and is not FDA/CE approved. It is only to be used for training purposes for healthcare staff. ThinkSono AI is a separate product from AuotDVT.
AutoDVT is currently only used in clinical trials and not available for normal clinical use.
Still not ready to invest?
Let us keep you apprised of everything happening with ThinkSono so that when the time is right for you, you’ll know if it’s a good time for us.If you’re a non-UK investor, don’t worry you can still invest. Just contact us!